Endocrinology
- Dealing with the “T” (testosterone)
If a patient feels better when taking testosterone supplementation, is it the “T” or is it a placebo effect?
- Does my patient have testosterone deficiency?
Diagnosis of testosterone deficiency requires the presence of relevant signs or symptoms along with biochemical evidence.
- It’s a new year, looking back and looking forward
Reflections on highlights from 2023 and impending changes in 2024, along with some acknowledgments and farewells.
- 2023 Update in ambulatory general internal medicine
Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.
- Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.
- Inpatient glycemic management in noncritically ill patients: Updated guidelines
The guidelines include a role for newer diabetes technologies and nontraditional insulin and noninsulin therapies.
- Born again: The many lives of metformin
Repurposing old drugs for new indications is not a new drug-development strategy.